Funding for this research was provided by:
Academy of Finland (25013080481, 25013142041)
Competitive State Research Financing of the Expert Responsibility area of Fimlab Laboratories (X51409)
City of Tampere Science Foundation
Tampere Tuberculosis Foundation
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
Received: 25 March 2019
Accepted: 2 August 2019
First Online: 13 August 2019
Ethics approval and consent to participate
: The study protocol was approved by the ethics committee of the city of Tampere (1592/403/1996) and the study was conducted according to the principles expressed in the declaration of Helsinki. The study participants provided their written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.